BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16870790)

  • 21. Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.
    Seefeld MA; Miller WH; Newlander KA; Burgess WJ; Payne DJ; Rittenhouse SF; Moore TD; DeWolf WE; Keller PM; Qiu X; Janson CA; Vaidya K; Fosberry AP; Smyth MG; Jaworski DD; Slater-Radosti C; Huffman WF
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2241-4. PubMed ID: 11527706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
    Mitton-Fry MJ; Brickner SJ; Hamel JC; Brennan L; Casavant JM; Chen M; Chen T; Ding X; Driscoll J; Hardink J; Hoang T; Hua E; Huband MD; Maloney M; Marfat A; McCurdy SP; McLeod D; Plotkin M; Reilly U; Robinson S; Schafer J; Shepard RM; Smith JF; Stone GG; Subramanyam C; Yoon K; Yuan W; Zaniewski RP; Zook C
    Bioorg Med Chem Lett; 2013 May; 23(10):2955-61. PubMed ID: 23566517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verrulactones D and E with unprecedented skeletons, new inhibitors of Staphylococcus aureus enoyl-ACP reductase, from Penicillium verruculosum F375.
    Kim N; Sohn MJ; Koshino H; Kim WG
    J Antibiot (Tokyo); 2016 Feb; 69(2):114-8. PubMed ID: 26306815
    [No Abstract]   [Full Text] [Related]  

  • 24. Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening.
    Zhang Q; Yu C; Min J; Wang Y; He J; Yu Z
    J Mol Model; 2011 Jun; 17(6):1483-92. PubMed ID: 20862594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of
    Rutherford JT; Avad K; Dureja C; Norseeda K; Gc B; Wu C; Sun D; Hevener KE; Hurdle JG
    ACS Infect Dis; 2024 May; 10(5):1612-1623. PubMed ID: 38597503
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251.
    Zheng CJ; Sohn MJ; Chi SW; Kim WG
    J Microbiol Biotechnol; 2010 May; 20(5):875-80. PubMed ID: 20519910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystallization and preliminary X-ray analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae.
    Saito J; Yamada M; Watanabe T; Kitagawa H; Takeuchi Y
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):576-8. PubMed ID: 16754986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI).
    Sampson PB; Picard C; Handerson S; McGrath TE; Domagala M; Leeson A; Romanov V; Awrey DE; Thambipillai D; Bardouniotis E; Kaplan N; Berman JM; Pauls HW
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5355-8. PubMed ID: 19682901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
    Hrast M; Anderluh M; Knez D; Randall CP; Barreteau H; O'Neill AJ; Blanot D; Gobec S
    Eur J Med Chem; 2014 Feb; 73():83-96. PubMed ID: 24384549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening assay for inhibitors of a recombinant Streptococcus pneumoniae UDP-glucose pyrophosphorylase.
    Zavala A; Kovacec V; Levín G; Moglioni A; Miranda MV; García E; Bonofiglio L; Mollerach M
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):203-207. PubMed ID: 28114831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor.
    Schiebel J; Chang A; Shah S; Lu Y; Liu L; Pan P; Hirschbeck MW; Tareilus M; Eltschkner S; Yu W; Cummings JE; Knudson SE; Bommineni GR; Walker SG; Slayden RA; Sotriffer CA; Tonge PJ; Kisker C
    J Biol Chem; 2014 Jun; 289(23):15987-6005. PubMed ID: 24739388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.
    Ronkin SM; Badia M; Bellon S; Grillot AL; Gross CH; Grossman TH; Mani N; Parsons JD; Stamos D; Trudeau M; Wei Y; Charifson PS
    Bioorg Med Chem Lett; 2010 May; 20(9):2828-31. PubMed ID: 20356737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complestatin exerts antibacterial activity by the inhibition of fatty acid synthesis.
    Kwon YJ; Kim HJ; Kim WG
    Biol Pharm Bull; 2015; 38(5):715-21. PubMed ID: 25947917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-Pyridone derivatives as new inhibitors of bacterial enoyl-ACP reductase FabI.
    Kitagawa H; Kumura K; Takahata S; Iida M; Atsumi K
    Bioorg Med Chem; 2007 Jan; 15(2):1106-16. PubMed ID: 17095231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, in-vitro and in-silico study of novel thiazoles as potent antibacterial agents and MurB inhibitors.
    Sanad SMH; Ahmed AAM; Mekky AEM
    Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900309. PubMed ID: 31967349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli.
    Chhibber M; Kumar G; Parasuraman P; Ramya TN; Surolia N; Surolia A
    Bioorg Med Chem; 2006 Dec; 14(23):8086-98. PubMed ID: 16893651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile Infection.
    Marreddy RKR; Wu X; Sapkota M; Prior AM; Jones JA; Sun D; Hevener KE; Hurdle JG
    ACS Infect Dis; 2019 Feb; 5(2):208-217. PubMed ID: 30501172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis and mechanism of enoyl reductase inhibition by triclosan.
    Stewart MJ; Parikh S; Xiao G; Tonge PJ; Kisker C
    J Mol Biol; 1999 Jul; 290(4):859-65. PubMed ID: 10398587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cephalochromin, a FabI-directed antibacterial of microbial origin.
    Zheng CJ; Sohn MJ; Lee S; Hong YS; Kwak JH; Kim WG
    Biochem Biophys Res Commun; 2007 Nov; 362(4):1107-12. PubMed ID: 17825252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.